Abstract
Liver fibrosis is characterized by an activation of hepatic stellate cells (HSC). During primary culture HSC evolve from a quiescent into an activated phenotype which is characterized by α-smooth muscle actin (α-SMA) up-regulation, increase in cell growth, and extracellular matrix secretion. HSC culture with trans-resveratrol can lead to deactivation of myofibroblast-like HSC. We used an HSC line, PAV-1, to check the role of retinol and palmitic acid in the deactivation process of HSC. Using mass and metabolic-based methods, Western blot and immunocytochemistry assays, we demonstrated that treatment with palmitic acid (75 μM) alone or in combination with retinol (2 μM) significantly decreased cell proliferation and α-SMA expression. We also established that the association of both compounds strongly decreased collagen type I expression. Our results suggest the potential use of palmitic acid alone or in combination with retinol to induce HSC deactivation.
Similar content being viewed by others
References
Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247–2250
Geerts A (2001) History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells. Semin Liver Dis 21:311–335
Godichaud S, Krisa S, Couronne B, Dubuisson L, Merillon JM, Desmouliere A, Rosenbaum J (2000) Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 31:922–931
Sohara N, Znoyko I, Levy MT, Trojanowska M, Reuben A (2002) Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. J Hepatol 37:214–221
Bennett R, Kharbanda K, Tuma D (2003) Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem Pharmacol 66:867–874
Russell RM, Boyer JL, Bagheri SA, Hruban Z (1974) Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites. N Engl J Med 291:435–440
Geubel AP, De Galocsy C, Alves N, Rahier J, Dive C (1991) Liver damage caused by therapeutic vitamin A administration: estimate of dose related toxicity in 41 cases. Gastroenterology 100:1701–1709
Jorens PG, Michielsen PP, Pelckmans PA, Fevery J, Desmet V, Geubels AP, Rahier J, Van Maercke YM (1992) Vitamin A abuse: development of cirrhosis despite cessation of vitamin A. A six-year clinical and histopathologic follow-up. Liver 12:381–386
Kowalski TE, Falestiny M, Furth E, Malet PF (1994) Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements. Am J Med 97:523–528
Okuno M, Moriwaki H, Imai S, Muto Y, Kawada N, Suzuki Y, Kojima S (1997) Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-β in liver stellate cells. Hepatology 26:913–921
Senoo H, Wake K (1985) Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab Invest 52:182–194
Shiratori Y, Ichida T, Geerts A, Wisse E (1987) Modulation of collagen synthesis by fat-storing cells, isolated from CCl4- or vitamin A-treated rats. Dig Dis Sci 32:1281–1289
Seifert WF, Bosma A, Hendriks HFJ, De Ruiter GCF, Van Leeuwen REW, Knook DL, Brouwer A (1989) Dual role of vitamin A in experimentally induced liver fibrosis. In: Wisse E, Knook DL, Decker K (eds) Cells of the hepatic sinisoids 2. The Kupffer Cell Foundation, Rijswijk, the Netherlands, pp 43–48
Parise E, Chehter L, Nogueira M, Leite-Mor M, Tersariol I, Michelacci Y, Nader H (1992) Effects of vitamin A administration on collagen and sulfated glycosaminoglycans contents in the livers of rats with carbon tetrachloride. J Lab Clin Med 119:676–681
Seifert W, Bosma A, Brouwer A, Hendriks H, Boholl P, van Leeuwen R, van Thiel-de Ruiter, Seifert-Bock I, Knook D (1994) Vitamin A deficiency potentiates carbon tetrachloride-induced liver fibrosis in rats. Hepatology 19:193–201
Seifert WF, Bosma A, Hendriks HFJ, Van Leeuwen REW, Van Thiel-de Ruiter GCF, Seifert-Bock I, Knook DL, Brouwer A (1995) Beta-carotene (provitamin A) decreases the severity of CCl4-induced hepatic inflammation and fibrosis in rat. Liver 15:1–8
Mizobuchi Y, Shimizu I, Yasuda M, Hori H, Shono M, Ito S (1998) Retnyl palmitate reduces hepatic fibrosis in rats induced dimethylnitrosamine or pig serum. J Hepatol 29:933–943
De Freitas Junior S, Bustorff-Silva JM, Castro e Silva Junior O, Jorge Gde L, Leonardi LS (2003) Retinyl-palmitate reduces liver fibrosis induced by biliary obstruction in rats. Hepatogastroenterology 50:146–150
Okuno M, Muto Y, Moriwaki H, Kato M, Noma A, Tagaya O, Nozaki Y, Suzuki Y (1990) Inhibitory effect of acyclic retinoid on hepatic fibrosis in CCl4 treated-rats. Gastroenterol Jpn 25:223–229
Vollmar B, Heckmann C, Richter S, Menger M (2002) High, but not low, dietary retinoids aggravate manifestation of rat liver fibrosis. J Gastroenterol Hepatol 17:791–99
Leo MA, Lieber CS (1999) Alcohol, vitamin A, and β-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 69:1071–1085
Okuno M, Kojima S, Akita K, Matsushima-Nishiwaki R, Adachi S, Sano T, Takano Y, Takai K, Obora A, Yasuda I, Shiratori Y, Okano Y, Shimada J, Suzuki Y, Muto Y, Moriwaki H (2002) Retinoids in liver fibrosis and cancer. Front Biosci 7:204–218
Borojevic R, Monteiro AN, Vinhas SA, Domont GB, Mourao PA, Emonard H, Grimaldi G Jr, Grimaud JA (1985) Establishment of a continuous cell line from fibrotic schistosomal granulomas in mice livers. In Vitro Cell Dev Biol 7:382–390
Weill FX, Blazejewski S, Blanc JF (1997) Characterisation of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor I by transforming growth factor beta 1. Lab Invest 77:63–70
Murakami K, Abe T, Miyazawa M, Yamaguchi M, Masuda T, Matsuura T, Nagamori S, Takeuchi K, Abe K, Kyogoku M (1995) Establishment of a new human cell line, LI 90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest 72:731–739
Schnabl B, Choi YH, Olsen JC, Hagedom CH, Brenner DA (2002) Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Lab Invest 82:223–232
Xu L, Hui A, Arthur MJ, O’Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54:142–151
Greenwel P, Schwartz M, Rosas M, Peyrol S, Grimaud JA, Rojkind M (1991) Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest 65:644–653
Greenwel P, Rubin J, Schwartz M, Hertzberg EL, Rojkind M (1993) Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6 and connexin 43. Lab Invest 69:210–216
Sauvant P, Sapin V, Abergel A, Schmidt CK, Blanchon L, Alexandre-Gouabau MC, Rosenbaum J, Bommelaer G, Rock E, Dastugue B, Nau H, Azaïs-Braesco V (2002) PAV-1, a new rat hepatic stellate cell line converts retinol into retinoic acid, a process altered by ethanol. Int J Biochem Cell Biol 34:1017–1029
Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, Blaner WS (2000) An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41:882–893
Sauvant P, Abergel A, Partier A, Alexandre-Gouabau MC, Rock E, Sion B, Motta C, Sapin V, Azaïs-Braesco V (2002) Treatment of the rat hepatic stellate cell line, PAV-1, by retinol and palmitic acid leads to a convenient model to study retinoids metabolism. Biol Cell 94:401–408
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Lowry OH, Rosebrough NJ, Frazer AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275
Labarca C, Paigen K (1980) A simple and sensitive DNA assay procedure. Anal Biochem. 102:344–352
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Towbin H, Staehlin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 166:209–214
Troen G, Nilsson A, Norum K, Blomhoff R (1994) Characterization of liver stellate cell retinyl ester storage. Biochem J 300:793–798
Davis B, Vucic A (1988) The effect of retinol on Ito cell proliferation in vitro. Hepatology 8:788–793
Geerts A, Vrijsen R, Schellinck P, Wisse E (1989) Retinol affects the phenotype and protein synthesis of fat-storing cell derived myofibroblasts in vitro. In: Wisse E, Knook DL, Decker K (eds) Cells of the hepatic sinusoids 2. The Kupffer Cell Foundation, Rijswijk, the Netherlands, pp 20–24
Davis B, Kramer R, Davidson N (1990) Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest 86:2062–2070
Davis B, Rapp U, Davidson N (1991) Retinoic acid and trnsforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem J 278:43–47
Pinzani M, Gentilini P, Abboud H (1992) Phenotypical modulation of liver fat-storing cells by retinoids. J Hepatol 14:211–220
Margis R, Pinheiro-Margis M, da Silva LC, Borojevic R (1992) Effects of retinol on proliferation, cell adherence and extracellular matrix synthesis in a liver myofibroblast or lipocyte cell line (GRX). Int J Exp Pathol 73:125–135
Sato S, Kato R, Tyson C (1995) Regulation of differentiated phenotype on rat lipocytes by retinoids in primary culture. Exp Cell Res 217:72–83
Okuno M, Sato T, Kitamoto T, et al. (1999) Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. J Hepatol 30:1073–1080
Hellemans K, Grinko I, Rombouts K, Schuppan D, Geerts A (1999) All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially. Gut 45:134–142
Huang G, Zhang J, Zhang Y (2000) Effects of retinoic acid on proliferation, phenotype and expression of cyclin-dependent kinase inhibitors in TGF-beta 1-stimulated rat hepatic stellate cells. World J Gastroenterol 6:819–823
Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, Casini A (2000) Peroxisome Proliferator activated receptor gamma transcriptional regulation is involved in PDGF-induced proliferation of human hepatic stellate cells. Hepatology 31:101–108
Hellemans K, Michalik L, Dittie A, Knorr A, Rombouts K, De Jong J, Heirman C, Quartier E, Schuit F, Walter W, Geerts A (2003) PPAR-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 124:184–201
Tronstad K, Berge K, Flindt E, Kristiansen K, Berge R (2001) Optimization of methods and treatment conditions of fatty acids on cell growth. Lipids 36:305–313
Beeharry N, Lowe J, Hernandes A, Chambers J, Fucassi F, Cragg P, Green M, Green I (2003) Linoleic acid and antioxidants protect against DNA damage and apoptosis induced by palmitic acid. Mutation Res 530:27–33
Kliewer S, Sundseth S, Jones S, Brown P, Wisely B, Koble C, Devchand P, Walter W, Willson T, Lenhard J, Lehmamm J (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318–4323
Yoshizawa K, Cioca D, Kawa S, Tanaka E, Kiyosawa K (2002) Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Cancer 95:2243–2251
Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath M (2001) Distinct effects of satured and monounsatured fatty acids on beta-cell turnover and function. Diabetes 50:69–76
Mathias S, Peña L, Kolesnick R (1998) Signal transduction of stress via ceramide. Biochem J 335:465–480
Nano JL, Nobili C, Girard-Pipau F, Rampal P (2003) Effects of fatty acids on the growth of Caco-2 cells. Prostag Leukotr Ess Fatty Acids 69:207–215
Petit-frere C, Capulas E, Lyon D, Norbury C, Lowe J, Clingen P, Riballo E, Green M, Arlett C (2000) Apoptosis and cytokine release induced by ionizing or ultraviolet B radiation in primary and im-mortalized human keratinocytes. Carcinogenesis 21:1087–1095
Weiner F, Blaner W, Czaja M, Shah A, Geerts A (1992) Ito cell expression of a nucleic acid receptor. Hepatology 15:336–342
Ohata M, Lin M, Satre M, Tsukamoto H (1997) Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver disease. Am J Physiol 272:G589–G596
Imai S, Okuno M, Moriwaki H, Muto Y, Murakami K, Shudo K, Suzuki Y, Kojima S (1997) 9,13-Di-cis retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI 90. FEBS Lett 411:102–106
Ulven SM, Natarajan V, Holven KB, Lovdal T, Berg T, Blomhoff R (1998) Expression of retinoic acid receptor and retinoid X receptor subtypes in rat liver cells: implications for retinoid signalling in parenchymal, endothelial, Kupffer and stellate cells. Eur J Cell Biol 77:111–116
Xu G, Bochaton-Piallat ML, Andreutti D, Low R, Gabbiani G, Neuville P (2001) Regulation of alpha-smooth muscle actin and CRBP-1 expression by retinoic acid and TGF-beta in cultured fibroblasts. J Cell Physiol 187:315–325
Hellemans K, Rombouts K, Quartier E, Dittie A, Knorr A, Michalik L, Rogiers V, Schuit F, Walter W, Geerts A (2003) PPAR-beta regulates vitamin A metabolism-related expression in hepatic stellate cells undergoing activation. J Lipid Res 44:280–295
Andreola F, Calvisis D, Elizondo G, Jakowlew S, Mariano J, Gonzalez F, De Luca L (2004) Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion. Hepatology 39:157–166
Acknowledgment
We thank Alexis Desmoulières (Bordeaux, France) for reviewing the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abergel, A., Sapin, V., Dif, N. et al. Growth Arrest and Decrease of α-SMA and Type I Collagen Expression by Palmitic Acid in the Rat Hepatic Stellate Cell Line PAV-1. Dig Dis Sci 51, 986–995 (2006). https://doi.org/10.1007/s10620-005-9031-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-9031-y